Biomolecular Engineering

Biomolecular engineering is an emerging field of academic research and industrial practice having the goal of engineering value-added biomolecules and biomolecular processes for applications in medical, chemical, agricultural, and food industries. This new subject is very broad and highly interdisciplinary, including, but is not limited to, protein engineering, metabolic engineering, bioinformatics, bioprocessing, gene therapy, drug design, discovery and delivery, biomaterials, and nano-biotechnology. In the past decades, biomolecules such as protein pharmaceuticals, DNA vaccines, monoclonal antibodies, and industrial enzymes have been increasingly commercialized. In this entry, the key concepts and technologies in biomolecular engineering and their applications in engineering proteins, pathways, and nucleic acids are introduced.

[1]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[2]  T. Cech,et al.  In vitro splicing of the ribosomal RNA precursor of tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence , 1981, Cell.

[3]  S. Klußmann,et al.  Spiegelmers: Biostable Aptamers , 2003, Chembiochem : a European journal of chemical biology.

[4]  D. Ryu,et al.  Recent Progress in Biomolecular Engineering , 2000, Biotechnology progress.

[5]  Z. Shabarova,et al.  The use of BrCN for assembling modified DNA duplexes and DNA-RNA hybrids; comparison with water-soluble carbodiimide. , 1991, Nucleic acids research.

[6]  Denis Pompon,et al.  Total biosynthesis of hydrocortisone from a simple carbon source in yeast , 2003, Nature Biotechnology.

[7]  Peter D. J. Grootenhuis,et al.  Practical Evaluation of Comparative Modelling and Threading Methods , 1998, Comput. Chem..

[8]  H. S. Kim,et al.  Amplification of toluene dioxygenase genes in a hybrid Pseudomonas strain to enhance the biodegradation of benzene, toluene, and p‐xylene mixture , 1995, Biotechnology and bioengineering.

[9]  T. Cech,et al.  Ribozyme-mediated repair of defective mRNA by targeted trans-splicing , 1994, Nature.

[10]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[11]  S. Hoeprich,et al.  Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus , 2003, Gene Therapy.

[12]  V. Erdmann,et al.  Mirror-image RNA that binds D-adenosine , 1996, Nature Biotechnology.

[13]  O. Gryaznova,et al.  Site-directed modification of DNA duplexes by chemical ligation. , 1988, Nucleic acids research.

[14]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[15]  M. Reitz,et al.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Stemmer,et al.  Genome shuffling leads to rapid phenotypic improvement in bacteria , 2002, Nature.

[17]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[18]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[19]  G. Bennett,et al.  Modification of central metabolic pathway in escherichia coli to reduce acetate accumulation by heterologous expression of the bacillus subtilis acetolactate synthase gene , 1994, Biotechnology and bioengineering.

[20]  George N. Bennett,et al.  Genetic and metabolic engineering , 1998 .

[21]  B. Sullenger,et al.  Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Gill.  Enabling inverse metabolic engineering through genomics. , 2003, Current opinion in biotechnology.

[23]  G. Stephanopoulos.  Metabolic fluxes and metabolic engineering. , 1999, Metabolic engineering.

[24]  Vassily Hatzimanikatis,et al.  Inverse metabolic engineering: a strategy for directed genetic engineering of useful phenotypes. , 2002, Biotechnology and bioengineering.

[25]  G. F. Joyce,et al.  A general purpose RNA-cleaving DNA enzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Klußmann,et al.  Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. , 2003, Nucleic acids research.

[27]  V. Gavrilovic,et al.  Genome shuffling of Lactobacillus for improved acid tolerance , 2002, Nature Biotechnology.

[28]  V. Schellenberger,et al.  Rapid Evolution of Novel Traits in Microorganisms , 2001, Applied and Environmental Microbiology.

[29]  M. Kumar,et al.  The commercial production of chemicals using pathway engineering. , 2000, Biochimica et biophysica acta.

[30]  R Cedergren,et al.  Numbering system for the hammerhead. , 1992, Nucleic acids research.

[31]  G. Bennett,et al.  Effect of Modulated Glucose Uptake on High‐Level Recombinant Protein Production in a Dense Escherichia coli Culture , 1994, Biotechnology progress.

[32]  C. Noe,et al.  Structural modifications of antisense oligonucleotides. , 2003, Farmaco.

[33]  T. Cech,et al.  Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena , 1982, Cell.

[34]  Cristina Romero-López,et al.  Ribozymes: recent advances in the development of RNA tools. , 2003, FEMS microbiology reviews.

[35]  Wolfgang Wiechert,et al.  Modeling and simulation: tools for metabolic engineering. , 2002, Journal of biotechnology.

[36]  P. Zamecnik,et al.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Corey.  Telomerase inhibition, oligonucleotides, and clinical trials , 2002, Oncogene.

[38]  N. Usman,et al.  Hammerhead ribozyme engineering. , 1996, Current opinion in structural biology.

[39]  J. Shendure,et al.  Selection analyses of insertional mutants using subgenic-resolution arrays , 2001, Nature Biotechnology.

[40]  S. Klußmann,et al.  In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Bennett,et al.  Metabolic flux analysis of Escherichia coli deficient in the acetate production pathway and expressing the Bacillus subtilis acetolactate synthase. , 1999, Metabolic engineering.

[42]  P. D. Cook,et al.  Structural origins of the exonuclease resistance of a zwitterionic RNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Evelyn Camon,et al.  The EMBL Nucleotide Sequence Database , 2004, Nucleic acids research.

[44]  S. Assinder,et al.  The TOL plasmids: determinants of the catabolism of toluene and the xylenes. , 1990, Advances in microbial physiology.